Association and Causation in Brain Imaging in the Case of OCD: Response to McKay Et Al.
Premika Boedhoe,Lianne Schmaal,David Mataix‐Cols,Neda Jahanshad,Paul M. Thompson,Dan J. Stein,Odile A. van den Heuvel,Yoshinari Abe,Pino Alonso,Stephanie H. Ameis,Paul Arnold,Núria Bargalló,Marcelo C. Batistuzzo,Francesco Benedetti,Jan C. Beucke,Irene Bollettini,Anushree Bose,Silvia Brem,Geraldo F. Busatto,Anna Calvo,Rosa Calvo,Daniëlle C. Cath,Yuqi Cheng,Kang Ik K. Cho,Sara Dallaspezia,Froukje E. de Vries,Stella J. de Wit,Damiaan Denys,Fei Yu,Kate D. Fitzgerald,Martine Fontaine,Jean‐Paul Fouché,Mónica Giménez,Patricia Gruner,Gregory L. Hanna,Derrek P. Hibar,Marcelo Q. Hoexter,Hao Hu,Chaim Huyser,Keisuke Ikari,Norbert Kathmann,Christian Kaufmann,Sabin Khadka,Kathrin Koch,Jun Soo Kwon,Luisa Lázaro,Yanni Liu,Christine Löchner,Rachel Marsh,Ignacio Martínez‐Zalacaín,José M. Menchón,Eurípedes C. Miguel,Luciano Minuzzii,Àstrid Morer,Takashi Nakamae,Tomohiro Nakao,Janardhanan C. Narayanaswamy,Fabrizio Piras,Christopher Pittenger,Y.C. Janardhan Reddy,João Ricardo Sato,H. Blair Simpson,Noam Soreni,Carles Soriano‐Mas,Michael C. Stevens,Philip R. Szeszko,David F. Tolin,Dick J. Veltman,Ganesan Venkatasubramanian,Ysbrand D. van der Werf,Guido A. van Wingen,Susanne Walitza,Zhen Wang,Jian Xu,Xiufeng Xu,Je‐Yeon Yun,Qing Zhao
DOI: https://doi.org/10.1176/appi.ajp.2017.17010019r
2017-01-01
Abstract:Back to table of contents Previous article Next article Letters to the EditorFull AccessAssociation and Causation in Brain Imaging in the Case of OCD: Response to McKay et al.Premika S.W. Boedhoe, M.Sc., Lianne Schmaal, Ph.D., David Mataix-Cols, Ph.D., Neda Jahanshad, Ph.D., ENIGMA OCD Working Group, Paul M. Thompson, Ph.D., Dan Stein, M.D., Ph.D., Odile A. van den Heuvel, M.D., Ph.D., Yoshinari Abe, M.D.; Pino Alonso, M.D., Ph.D.; Stephanie H. Ameis, M.D.; Paul D. Arnold, M.D., Ph.D.; Nuria Bargalló, Ph.D.; Marcelo C. Batistuzzo, Ph.D.; Francesco Benedetti, M.D.; Jan C. Beucke, Ph.D.; Premika S.W. Boedhoe, M.Sc.; Irene Bollettini, Psy.D.; Anushree Bose, M.A.; Silvia Brem, Ph.D.; Geraldo F. Busatto, M.D., Ph.D.; Anna Calvo, M.Sc.; Rosa Calvo, M.D., Ph.D.; Danielle C. Cath, M.D., Ph.D.; Yuqi Cheng, Ph.D.; Kang Ik K. Cho, B.Sc.; Sara Dallaspezia, M.D.; Froukje E. de Vries, M.D., M.Sc.; Stella J. de Wit, M.D., M.Sc.; Damiaan Denys, M.D., Ph.D.; Yu Fang, M.S.E.; Kate D. Fitzgerald, M.D.; Martine Fontaine, B.Sc.; Jean-Paul Fouche, M.Sc.; Mònica Giménez, Ph.D.; Patricia Gruner, Ph.D.; Gregory L. Hanna, M.D.; Derrek P. Hibar, Ph.D.; Marcelo Q. Hoexter, M.D., Ph.D.; Hao Hu, M.Sc.; Chaim Huyser, M.D., Ph.D.; Keisuke Ikari, M.D.; Neda Jahanshad, Ph.D.; Norbert Kathmann, Ph.D.; Christian Kaufmann, Ph.D.; Sabin Khadka, M.Sc.; Kathrin Koch, Ph.D.; Jun Soo Kwon, M.D., Ph.D.; Luisa Lazaro, M.D., Ph.D.; Yanni Liu, Ph.D.; Christine Lochner, Ph.D.; Rachel Marsh, Ph.D.; Ignacio Martínez-Zalacaín, M.Sc.; David Mataix-Cols, Ph.D.; José M. Menchón, M.D., Ph.D.; Euripedes C. Miguel, M.D., Ph.D.; Luciano Minuzzii, M.D., Ph.D.; Astrid Morer, M.D., Ph.D.; Takashi Nakamae, M.D., Ph.D.; Tomohiro Nakao, M.D., Ph.D.; Janardhanan C. Narayanaswamy, M.D.; Fabrizio Piras, Ph.D.; Federica Piras, Ph.D.; Christopher Pittenger, M.D., Ph.D.; Y.C. Janardhan Reddy, M.D.; Joao R. Sato, Ph.D.; H. Blair Simpson, M.D.; Lianne Schmaal, Ph.D.; Noam Soreni, M.D.; Carles Soriano-Mas, Ph.D.; Gianfranco Spalletta, M.D., Ph.D.; Dan J. Stein, M.D., Ph.D.; Michael C. Stevens, Ph.D.; Philip R. Szeszko, Ph.D.; Paul M. Thompson, Ph.D.; David F. Tolin, Ph.D.; Dick J. Veltman, M.D., Ph.D.; Ganesan Venkatasubramanian, M.D., Ph.D.; Odile A. van den Heuvel, M.D., Ph.D.; Ysbrand D. van der Werf, Ph.D.; Guido A. van Wingen, Ph.D.; Susanne Walitza, M.D., M.Sc.; Zhen Wang, M.D., Ph.D.; Jian Xu, Ph.D.; Xiufeng Xu, M.D.; Je-Yeon Yun, M.D., Ph.D.; Qing Zhao, M.D.Premika S.W. BoedhoeSearch for more papers by this author, M.Sc., Lianne SchmaalSearch for more papers by this author, Ph.D., David Mataix-ColsSearch for more papers by this author, Ph.D., Neda JahanshadSearch for more papers by this author, Ph.D., ENIGMA OCD Working GroupSearch for more papers by this author, Paul M. ThompsonSearch for more papers by this author, Ph.D., Dan SteinSearch for more papers by this author, M.D., Ph.D., Odile A. van den HeuvelSearch for more papers by this author, M.D., Ph.D., Published Online:1 Jun 2017https://doi.org/10.1176/appi.ajp.2017.17010019rAboutSectionsPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinked InEmail To the Editor: We thank McKay and colleagues for their comments, in which they expressed their concerns about the minimum effect size at which one may declare imaging results to be substantively, specifically, and causally related to putative psychopathological states. It is certainly important for the field to be aware of the extent of progress in brain imaging research in psychiatry and of key limitations that must be addressed.The first issue concerns the extent of structural changes seen in psychiatric disorders in general and in obsessive-compulsive disorder (OCD) in particular. OCD imaging studies have been performed using relatively small sample sizes, with inaccurate effect sizes in any particular study (1). With meta- and mega-analyses, we can put these results in context and better estimate true effect sizes. Admittedly, any abnormalities may remain subtle, and structural MRI provides only a crude and indirect measure of putative alterations at the molecular level. Nevertheless, small volumetric abnormalities can have profound effects on behavior. Indeed, Cohen’s (2) rules of thumb (suggesting an effect size of 0.20 is “small,” 0.50 is “medium,” and 0.80 is “large”) fail to address the point that even a very small effect size can help in understanding the pathophysiology of a disorder. Thus, single-nucleotide polymorphisms in genome-wide association studies may explain a very small percentage of trait variance but may still have robust effects, and in aggregate they may account for a substantial fraction of disease risk (3). For example, APOE and TREM2 genotypes explain only a small fraction of overall disease risk but are targets of major efforts in Alzheimer’s disease research and are being used to stratify patients in clinical trials (4). Similarly, subtle yet reproducible evidence for structural abnormalities in the hippocampal complex (where d equals approximately 0.4–0.5) has given rise to several models of hippocampal dysfunction in schizophrenia (5), which are supported by postmortem and animal studies of cellular and molecular mechanisms (6). Therefore, we do not advocate cutoffs as to which effect sizes should be reported. If effect sizes are not “censored,” future meta-analyses and even literature searches will be less affected by reporting bias.A second issue concerns the specificity of structural changes in brain imaging studies. McKay et al. argue that the thalamus abnormality we reported in pediatric OCD is not disease specific. It is becoming increasingly clear that mental disorders share genetic risk factors, and so not surprisingly, there is overlap in the brain circuits involved. There is value, however, in investigating the extent to which neurocircuitry overlaps across disorders or differentiates between conditions, and in determining the extent to which these overlaps and distinctions are from shared or specific genetic and environmental effects. Notably, results of very large-scale analyses by other working groups of the Enhancing NeuroImaging Genetics Through Meta-Analysis (ENIGMA) consortium, such as studies of schizophrenia (5), bipolar disorder (7), major depressive disorder (8), attention deficit hyperactivity disorder (9), and autism spectrum disorder (unpublished 2017 study of D. van Rooij et al.), do not show thalamus abnormalities in their patient groups. This thalamus abnormality thus seems somewhat specific to children with OCD. The main group comparison also showed a larger pallidum and smaller hippocampus in adult OCD patients. However, ENIGMA data suggest that reduced hippocampal volume may not be disease specific. The ENIGMA consortium is well positioned to investigate the consistency and specificity of neural correlates of neuropsychiatric disorders in its ongoing work.A third issue is causality. We agree with McKay et al. that we do not yet know if the brain abnormalities we have reported are the cause or consequence of the disorder or if they have a common cause. Nevertheless, taken together, a broad range of basic and clinical work has certainly provided mechanistic insights into how specific brain regions may contribute to OCD. Furthermore, the emerging picture from imaging and from genetics is that in psychiatry there are often multiple intersecting causes (10), some specific to a disorder and others not. Longitudinal twin studies of concordant and discordant cases are needed to disentangle genetic and environmental modulators of causes and consequences of disease. The larger pallidum in adult OCD appears to be driven by patients with an early disease onset, suggesting that this pallidum effect may be related to many years of repetitive behavior. This finding is repeatedly found in the literature and, despite its small effect size, is highly consistent with models of OCD. Large-scale studies such as ours are well powered to distinguish consistent, generalizable findings from false positives and so contribute to the consolidation of causal hypotheses. While the subcortical structures evaluated in this work do not yet encompass the entirety of brain structural networks and functions, the data provide important insight into what systems are more affected in OCD and promote further research to evaluate specific pathways implicated in the causes and consequences of this condition.From the Departments of Psychiatry and of Anatomy and Neurosciences, VU University Medical Center, Amsterdam; Amsterdam Neuroscience, Amsterdam; Orygen, The National Centre of Excellence in Youth Mental Health, Melbourne; the Department of Clinical Neuroscience, Centre for Psychiatric Research and Education, Karolinska Institutet, Stockholm; the Imaging Genetics Center, Keck School of Medicine, USC, Marina del Rey, Calif.; and SU/UCT Medical Research Council Unit on Anxiety and Stress Disorders, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa.Address correspondence to Ms. Boedhoe ([email protected]).The authors’ disclosures accompany the original article.References1 Button KS, Ioannidis JPA, Mokrysz C, et al.: Power failure: why small sample size undermines the reliability of neuroscience. Nat Rev Neurosci 2013; 14:365–376Crossref, Medline, Google Scholar2 Cohen J: Statistical Power Analysis for the Behavioral Sciences, 2nd ed. Mahway, NJ, Lawrence Earlbaum Associates, 1988, pp 20–26Google Scholar3 Zheng J, Erzurumluoglu AM, Elsworth BL, et al.: LD Hub: a centralized database and web interface to perform LD score regression that maximizes the potential of summary level GWAS data for SNP heritability and genetic correlation analysis. Bioinformatics 2017; 33:272–279Crossref, Medline, Google Scholar4 Naj AC: Alzheimer’s disease sequencing project: case-control analyses. Alzheimers Dement 2016; 12(July suppl):322Crossref, Google Scholar5 van Erp TGM, Hibar DP, Rasmussen JM, et al.: Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium. Mol Psychiatry 2016; 21:547–553; correction, 2016; 21:585Crossref, Medline, Google Scholar6 Bolkan SS, Carvalho Poyraz F, Kellendonk C: Using human brain imaging studies as a guide toward animal models of schizophrenia. Neuroscience 2016; 321:77–98Crossref, Medline, Google Scholar7 Hibar DP, Westlye LT, van Erp TGM, et al.: Subcortical volumetric abnormalities in bipolar disorder. Mol Psychiatry 2016; 21:1710–1716Crossref, Medline, Google Scholar8 Schmaal L, Veltman DJ, van Erp TGM, et al.: Subcortical brain alterations in major depressive disorder: findings from the ENIGMA Major Depressive Disorder working group. Mol Psychiatry 2016; 21:806–812Crossref, Medline, Google Scholar9 Hoogman M, Bralten J, Hibar DP, et al.: Subcortical brain volume differences in participants with attention deficit hyperactivity disorder in children and adults: a cross-sectional mega-analysis. Lancet Psychiatry (Epub ahead of print, Feb 16, 2017)Google Scholar10 Kendler KS: The dappled nature of causes of psychiatric illness: replacing the organic-functional/hardware-software dichotomy with empirically based pluralism. Mol Psychiatry 2012; 17:377–388Crossref, Medline, Google Scholar FiguresReferencesCited byDetailsCited byBrain Morphology Associated With Obsessive-Compulsive Symptoms in 2,551 Children From the General PopulationJournal of the American Academy of Child & Adolescent Psychiatry, Vol. 15S.04.04 The strengths and limitations of large-scale meta- and mega-analyses in pediatric and adult OCD: experience from the ENIGMA-OCD working groupEuropean Neuropsychopharmacology, Vol. 29Frontiers in Neuroinformatics, Vol. 12Cortical Abnormalities Associated With Pediatric and Adult Obsessive-Compulsive Disorder: Findings From the ENIGMA Obsessive-Compulsive Disorder Working GroupPremika S.W. Boedhoe, M.Sc., Lianne Schmaal, Ph.D., Yoshinari Abe, M.D., Pino Alonso, M.D., Ph.D., Stephanie H. Ameis, M.D., M.Sc., Alan Anticevic, Ph.D., Paul D. Arnold, M.D., Ph.D., Marcelo C. Batistuzzo, Ph.D., Francesco Benedetti, M.D., Jan C. Beucke, Ph.D., Irene Bollettini, Ph.D., Anushree Bose, M.A., Silvia Brem, Ph.D., Anna Calvo, M.Sc., Rosa Calvo, M.D., Ph.D., Yuqi Cheng, Ph.D., Kang Ik K. Cho, Ph.D., Valentina Ciullo, Ph.D., Sara Dallaspezia, M.D., Damiaan Denys, M.D., Ph.D., Jamie D. Feusner, M.D., Kate D. Fitzgerald, M.D., Jean-Paul Fouche, Ph.D., Egill A. Fridgeirsson, M.Sc., Patricia Gruner, Ph.D., Gregory L. Hanna, M.D., Derrek P. Hibar, Ph.D., Marcelo Q. Hoexter, M.D., Ph.D., Hao Hu, Ph.D., Chaim Huyser, M.D., Ph.D., Neda Jahanshad, Ph.D., Anthony James, M.D., Norbert Kathmann, Ph.D., Christian Kaufmann, Ph.D., Kathrin Koch, Ph.D., Jun Soo Kwon, M.D., Ph.D., Luisa Lazaro, M.D., Ph.D., Christine Lochner, Ph.D., Rachel Marsh, Ph.D., Ignacio Martínez-Zalacaín, M.Sc., David Mataix-Cols, Ph.D., José M. Menchón, M.D., Ph.D., Luciano Minuzzi, M.D., Ph.D., Astrid Morer, M.D., Ph.D., Takashi Nakamae, M.D., Ph.D., Tomohiro Nakao, M.D., Ph.D., Janardhanan C. Narayanaswamy, M.D., Seiji Nishida, M.D., Ph.D., Erika Nurmi, M.D., Ph.D., Joseph O’Neill, Ph.D., John Piacentini, Ph.D., Fabrizio Piras, Ph.D., Federica Piras, Ph.D., Y.C. Janardhan Reddy, M.D., Tim J. Reess, M.A., Yuki Sakai, M.D., Ph.D., Joao R. Sato, Ph.D., H. Blair Simpson, M.D., Ph.D., Noam Soreni, M.D., Carles Soriano-Mas, Ph.D., Gianfranco Spalletta, M.D., Ph.D., Michael C. Stevens, Ph.D., Philip R. Szeszko, Ph.D., David F. Tolin, Ph.D., Guido A. van Wingen, Ph.D., Ganesan Venkatasubramanian, M.D., Ph.D., Susanne Walitza, M.D., M.Sc., Zhen Wang, M.D., Ph.D., Je-Yeon Yun, M.D., Ph.D., , Paul M. Thompson, Ph.D., Dan J. Stein, M.D., Ph.D., Odile A. van den Heuvel, M.D., Ph.D., Premika S.W. Boedhoe, Lianne Schmaal, Yoshinari Abe, Pino Alonso, Stephanie H. Ameis, Alan Anticevic, Paul D. Arnold, Nuria Bargalló, Marcelo C. Batistuzzo, Francesco Benedetti, Jan C. Beucke, Irene Bollettini, Anushree Bose, Daniel Brandeis, Silvia Brem, Elizabeth Buimer, Geraldo F. Busatto, Anna Calvo, Rosa Calvo, Yuqi Cheng, Kang Ik K. Cho, Valentina Ciullo, Sara Dallaspezia, Froukje E. de Vries, Stella J. de Wit, Damiaan Denys, Renate Drechsler, Andrea Falini, Yu Fang, Jamie D. Feusner, Martijn Figee, Kate D. Fitzgerald, Martine Fontaine, Jean-Paul Fouche, Egill A. Fridgeirsson, Patricia Gruner, Gregory L. Hanna, Tobias U. Hauser, Derrek P. Hibar, Marcelo Q. Hoexter, Hao Hu, Chaim Huyser, Mariangela Iorio, Neda Jahanshad, Anthony James, Norbert Kathmann, Christian Kaufmann, Sabin Khadka, Kathrin Koch, Jun Soo Kwon, Luisa Lazaro, Yanni Liu, Christine Lochner, Rachel Marsh, Ignacio Martínez-Zalacaín, David Mataix-Cols, James T. McCracken, José M. Menchón, Euripedes C. Miguel, Luciano Minuzzi, Astrid Morer, Takashi Nakamae, Tomohiro Nakao, Janardhanan C. Narayanaswamy, Jin Narumoto, Seiji Nishida, Erika Nurmi, Joseph O’Neill, Jose C. Pariente, John Piacentini, Christopher Pittenger, Fabrizio Piras, Federica Piras, Sara Poletti, Y.C. Janardhan Reddy, Tim J. Reess, Oana G. Rus, Yuki Sakai, Joao R. Sato, H. Blair Simpson, Noam Soreni, Carles Soriano-Mas, Gianfranco Spalletta, Michael C. Stevens, Philip R. Szeszko, Jinsong Tang, David F. Tolin, Ysbrand D. van der Werf, Guido A. van Wingen, Daniela Vecchio, Dick J. Veltman, Ganesan Venkatasubramanian, Susanne Walitza, Zhen Wang, Anri Watanabe, Jian Xu, Xiufeng Xu, Kei Yamada, Je-Yeon Yun, Mojtaba Zarei, Qing Zhao, Paul M. Thompson, Dan J. Stein, Odile A. van den Heuvel15 December 2017 | American Journal of Psychiatry, Vol. 175, No. 5Journal of the American Academy of Child & Adolescent Psychiatry, Vol. 57, No. 1 Volume 174Issue 6 June 01, 2017Pages 597-599 Metrics KeywordsObsessive-Compulsive DisorderBrain Imaging TechniquesCausalityNeurodevelopmental DisorderNeuroimagingStructural MRIPDF download History Accepted 1 February 2017 Published online 1 June 2017 Published in print 1 June 2017